The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer: A Turkish Oncology Group (TOG) study

Author:

Demirkıran Aykut,Kılınç Fahriye,Koçak Mehmet Zahid,Demirkıran Deniz,Korkmaz Mustafa,Eryılmaz Melek Karakurt,Araz Murat,Karaağaç Mustafa,Artaç Mehmet

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Reference21 articles.

1. Arnold D, Lueza B, Douillard JY, Peeters M, Lenz HJ, Venook A, Heinemann V, Van Cutsem E, Pignon JP, Tabernero J, Cervantes A, Ciardiello F (2017) Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Ann Oncol 28(8):1713–1729. https://doi.org/10.1093/annonc/mdx175.PMID:28407110;PMCID:PMC6246616

2. Bylsma LC, Gillezeau C, Garawin TA, Kelsh MA, Fryzek JP, Sangaré L, Lowe KA. Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer Med. 2020 Feb;9(3):1044–1057. doi: https://doi.org/10.1002/cam4.2747. Epub 2019 Dec 19. PMID: 31856410; PMCID: PMC6997095.

3. Van Cutsem E, Cervantes A, Nordlinger B, Arnold D; ESMO Guidelines Working Group. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014 Sep;25 Suppl 3:iii1–9. doi: https://doi.org/10.1093/annonc/mdu260. Epub 2014 Sep 4. Erratum in: Ann Oncol. 2015 Sep;26 Suppl 5:v174–7. PMID: 25190710.

4. Holch JW, Ricard I, Stintzing S, Modest DP, Heinemann V (2017) The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials. Eur J Cancer 70:87–98. https://doi.org/10.1016/j.ejca.2016.10.007. (Epub 2016 Nov 29 PMID: 27907852)

5. Itatani Y, Kawada K, Sakai Y (2019) Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment. Int J Mol Sci 20(23):5822. https://doi.org/10.3390/ijms20235822.PMID:31756952;PMCID:PMC6929101

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3